Bespoke Extracts, Inc. Stock

Equities

BSPK

US08634Q2084

Pharmaceuticals

Market Closed - OTC Markets 03:17:09 2024-04-26 pm EDT 5-day change 1st Jan Change
0.0925 USD -15.83% Intraday chart for Bespoke Extracts, Inc. -15.83% +160.56%
Sales 2022 3.41K Sales 2023 785K Capitalization 361K
Net income 2022 -4M Net income 2023 -1M EV / Sales 2022 699 x
Net Debt 2022 671K Net Debt 2023 1.11M EV / Sales 2023 1.87 x
P/E ratio 2022
-0.46 x
P/E ratio 2023
-0.24 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 84.17%
More Fundamentals * Assessed data
Dynamic Chart
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bespoke Extracts, Inc. announced that it has received $0.1 million in funding CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Bespoke Extracts, Inc. entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million. CI
Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors CI
Bespoke Extracts, Inc. announced that it expects to receive $0.0922 million in funding from Infinity Management LLC and other investors CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021 CI
More news
1 day-15.83%
1 week-15.83%
Current month-20.94%
1 month-26.00%
3 months-3.34%
6 months-50.75%
Current year+160.56%
More quotes
1 week
0.09
Extreme 0.0925
0.11
1 month
0.06
Extreme 0.0605
0.16
Current year
0.02
Extreme 0.0186
1.00
1 year
0.02
Extreme 0.0186
1.00
3 years
0.02
Extreme 0.0186
1.78
5 years
0.02
Extreme 0.0186
4.57
10 years
0.02
Extreme 0.0186
135.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 21-11-18
President 35 21-10-31
Members of the board TitleAgeSince
Chief Executive Officer 53 21-11-18
President 35 21-10-31
More insiders
Date Price Change Volume
24-04-26 0.0925 -15.83% 367
24-04-24 0.1099 0.00% 5,001
24-04-22 0.1099 0.00% 500
24-04-18 0.1099 +81.35% 500

Delayed Quote OTC Markets, April 26, 2024 at 03:17 pm EDT

More quotes
Bespoke Extracts, Inc. operates in the regulated cannabis markets in the United States. The Company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints, to licensed marijuana dispensaries across Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates Wonderleaf LLC (WonderLeaf), a marijuana-infused products production facility in Aurora, Colorado. The Company manufactures a range of premium pre-rolled joints. The Company has offered cannabis products focusing on two primary categories: Branded Products and Processing Business. It plans to pursue production of brands of pre-rolled joints and other processed marijuana products under newly created brand names. It also plans to explore licensing existing brands from other states and producing them in Colorado.
More about the company